ResMed logo-fullcolor.jpg
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024 03:05 ET | ResMed Inc.
ResMed announced the results of its 2024 Global Sleep Survey, uncovering a world in sleep crisis and encouraging people to discover their sleep superpowers
ResMed logo-fullcolor.jpg
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024 09:05 ET | ResMed Inc.
ResMed unveils the AirFit F40, an ultra-compact full-face CPAP mask offering the comfort of smaller masks without sacrificing performance.
Apnimed.png
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
March 06, 2024 08:00 ET | Apnimed, Inc.
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
Sleep & Headache Sol
Sleep & Headache Solutions Expands Reach to New Locations, Offering Comprehensive Sleep Apnea Treatments
March 05, 2024 09:54 ET | Sleep & Headache Solutions
Boone, NC, March 05, 2024 (GLOBE NEWSWIRE) -- Sleep & Headache Solutions has recently expanded its services by establishing two new practice locations in Boone and Mount Airy, North Carolina....
PRO3-420-A ProSomnus, Inc Logo_horizontal.png
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
February 22, 2024 08:30 ET | ProSomnus Sleep Technologies, Inc.
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
Apnimed.png
Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference
February 22, 2024 08:00 ET | Apnimed, Inc.
Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference
PRO3-420-A ProSomnus, Inc Logo_horizontal.png
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
January 30, 2024 08:00 ET | ProSomnus Sleep Technologies, Inc.
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
PRO3-420-A ProSomnus, Inc Logo_horizontal.png
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
January 29, 2024 08:00 ET | ProSomnus Sleep Technologies, Inc.
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
Global Sleep Apnea Oral Appliances Market
Sleep Apnea Oral Appliances Market Global Forecast to 2028 - Market Poised for Robust Growth to $0.9 Billion, Up from $0.4 Billion in 2023, Dominated by Mandibular Advancement Devices
January 11, 2024 10:23 ET | Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type...